Stock Events

Stock Events

Statera BioPharma 

$0
15
-$0-75% Tuesday 13:30

Statistics

Day High
0
Day Low
0
52W High
0.01
52W Low
0
Volume
700
Avg. Volume
59,286
Mkt Cap
5,074.5
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

29MarExpected
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
Q4 2022
-1.42
-0.95
-0.47
0
Expected EPS
N/A
Actual EPS
N/A

Financials

-6,849.43%Profit Margin
Unprofitable
2016
2017
2018
2019
2020
2021
2.97MRevenue
-203.7MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow STAB. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap148.78B
Gilead Sciences is a biopharmaceutical company that competes in the development of treatments for infectious diseases, a field Statera BioPharma is also involved in.
AMGEN
AMGN
Mkt Cap160.66B
Amgen is a biotech firm focusing on novel therapies, including for autoimmune diseases, which overlaps with Statera BioPharma's research interests.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol Myers Squibb operates in the biopharmaceutical sector, focusing on cancer and immune system disorders, areas Statera BioPharma is exploring.
Merck
MRK
Mkt Cap214.76B
Merck is known for its contributions to healthcare, including cancer and infectious diseases, competing with Statera BioPharma's research domains.
Pfizer
PFE
Mkt Cap140.15B
Pfizer engages in the discovery, development, and manufacture of healthcare products including vaccines, directly competing with some of Statera BioPharma's focus areas.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie works on advanced therapies for severe illnesses including autoimmune diseases, directly in competition with Statera BioPharma's interests.
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
Regeneron Pharmaceuticals specializes in the invention of medicines for serious medical conditions, competing with Statera BioPharma in the biopharmaceutical field.
Novartis
NVS
Mkt Cap237.61B
Novartis focuses on a wide range of healthcare areas including those being pursued by Statera BioPharma, making it a direct competitor.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson, through its pharmaceutical division, competes across various healthcare sectors, including those relevant to Statera BioPharma.
Astrazeneca
AZN
Mkt Cap256.58B
AstraZeneca is a global, science-led biopharmaceutical business that competes with Statera BioPharma in developing treatments for various diseases.

About

Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses, and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. The company is developing therapies designed to directly elicit within patients a response of antigen-specific killer T-cells and antibodies, thereby activating essential immune defenses against autoimmune, inflammatory, infectious diseases, and cancers. It has clinical programs for Crohn's disease (STAT-201), hematology (Entolimod), pancreatic cancer (STAT-401), and COVID-19 (STAT-205), as well as expanding into fibromyalgia and multiple sclerosis. The company was formerly known as Cytocom, Inc. and changed its name to Statera Biopharma, Inc. in September 2021. The company is based in Fort Collins, Colorado.
Show more...
CEO
Dr. Blake Hawley D.V.M., M.B.A.
Employees
46
Country
US
ISIN
US8575611046

Listings

OTC Link
US
STAB

0 Comments

Share your thoughts

FAQ

What is Statera BioPharma stock price today?▼
The current price of STAB is $0 USD — it has decreased by -75% in the past 24 hours. Watch Statera BioPharma stock price performance more closely on the chart.
What is Statera BioPharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Statera BioPharma stocks are traded under the ticker STAB.
What is Statera BioPharma market cap?▼
Today Statera BioPharma has the market capitalization of 5,074.5
What is Statera BioPharma revenue for the last year?▼
Statera BioPharma revenue for the last year amounts to 2.97M USD.
What is Statera BioPharma net income for the last year?▼
STAB net income for the last year is -203.7M USD.
How many employees does Statera BioPharma have?▼
As of April 01, 2026, the company has 46 employees.
In which sector is Statera BioPharma located?▼
Statera BioPharma operates in the Health Care sector.
When did Statera BioPharma complete a stock split?▼
The last stock split for Statera BioPharma was on January 28, 2015 with a ratio of 1:20.
Where is Statera BioPharma headquartered?▼
Statera BioPharma is headquartered in Fort Collins, US.